Verition Fund Management »

Immunovant shares owned by Verition Fund Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $302k 9.4k 32.31
2023-03-31 $386k 25k 15.51

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant